Improvement in the quality of live in heroin addicts: Differences between methadone and buprenorphine treatment

Heroin Addiction and Related Clinical Problems

Volumn 10, Issue 1, 2008, Pages 39-46

  Maremmani, Icro ^a,b,c,f   Pani, Pier Paolo ^d   Popovic, Dina ^a   Pacini, Matteo ^a,c   Deltito, Joseph ^e   Perugi, Giulio ^a,c  

^a UNIVERSITY OF PISA   (Italy)

^b AU CNS   (Italy)

^c G DE LISIO INSTITUTE OF BEHAVIOURAL SCIENCES   (Italy)

^d Sardinia Health and Social Administration   (Italy)

^e NEW YORK MEDICAL COLLEGE   (United States)

^f UNIVERSITY OF PISA   (Italy)

Author keywords

Buprenorphine; Methadone treatment; Psychiatric comorbidity; Quality of life; Response predictors to treatment outcome; Retention

Indexed keywords

BUPRENORPHINE; DIAMORPHINE; METHADONE;

ADULT; ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; DRUG DEPENDENCE TREATMENT; FEMALE; HEROIN DEPENDENCE; HUMAN; INCOME; JOB PERFORMANCE; LEISURE; MAINTENANCE THERAPY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; QUALITY OF LIFE; SELF CONCEPT; SUBSTANCE ABUSE; TREATMENT OUTCOME;

EID: 41649115813     PISSN: 15921638     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. BLAU T. H. (1977): Quality of Life, social indicators and criteria of change. Prof Psychol. 8:(6) 464-473.
2. CONNOCK M., JUAREZ-GARCIA A., JOWETT S., FREW E., LIU Z., TAYLOR R. J., FRY-SMITH A., DAY E., LINTZERIS N., ROBERTS T., BURLS A., TAYLOR R. S. (2007): Methadone and buprenorphine for the management of opioid dependence: a systematic review and economic evaluation. Health Technol Assess. 11:(9) 1-171, iii-iv.
3. GOURLAY J., RICCIARDELLI L., RIDGE D. (2005): Users' experiences of heroin and methadone treatment. Subst Use Misuse. 40:(12) 1875-1882.
4. HAASEN C., VAN DEN BRINK W. (2006): Innovations in agonist maintenance treatment of opioid-dependent patients. Curr Opin Psychiatry. 19:(6) 631-636.
5. HUNT D. E., LIPTON D. S., GOLDSMITH D. S., STRUG D. L., SPUNT B. (1985): "It takes your heart": the image of methadone maintenance in the addict world and its effect on recruitment into treatment. Int J Addict. 20:(11-12) 1751-1771.
6. KAKKO J., GRONBLADH L., SVANBORG K. D., VON WACHENFELDT J., RUCK C., RAWLINGS B., NILSSON L. H., HEILIG M. (2007): A stepped care strategy using buprenorphine and methadone versus conventional methadone maintenance in heroin dependence: a randomized controlled trial. Am J Psychiatry. 164:(5) 797-803.
7. KRISTENSEN O., ESPEGREN O., ASLAND R., JAKOBSEN E., LIE O., SEILER S. (2005): [Buprenorphine and methadone to opiate addicts - a randomized trial]. Tidsskr Nor Laegeforen. 125:(2) 148-151.
8. LEWIS D. C. (1999): Access to narcotic addiction treatment and medical care: prospects for the expansion of methadone maintenance treatment. J Addict Dis. 18:(2) 5-21.
9. LING W., WESSON D. R. (2003): Clinical efficacy of buprenorphine: comparisons to methadone and placebo. Drug Alcohol Depend. 70:(2 Suppl) S49-57.
10. MAREMMANI I., BARRA M., BIGNAMINI E., CONSOLI A., DELL'AERA S., DERUVO G., FANTINI F., FASOLI M. G., GATTI R., GESSA G. L., GUELFI G. P., JARRE P., MICHELAZZI A., MOLLICA R., NARDINI R., PANI P. P., POLIDORI E., SIRAGUSA C., SPAZZAPAN B., STARACE F., TAGLIAMONTE A., TIDONE L., VENDRAMIN A. (2002): Clinical foundations for the use of methadone. Italian Consensus Panel on Methadone Treatment. Heroin Addict Relat Clin Probl. 4:(2) 19-31.
11. MAREMMANI I., CASTROGIOVANNI P. (1989): DAH-RS: Drug Addiction History Rating Scale. University Press, Pisa.
12. MAREMMANI I., PANI P. P., PACINI M., PERUGI G. (2007): Substance use and quality of life over 12 months among buprenorphine maintenance-treated and methadone maintenance-treated heroin-addicted patients. J Subst Abuse Treat. 33:(1) 91-98.
13. PARRINO M. W. (1993): State Methadone Treatment Guidelines. Treatment Improvement Protocol (TIP) Series, 1. U.S. Department of Health and Human Services, Rockville, MD.
14. PONIZOVSKY A. M., GRINSHPOON A. (2007): Quality of life among heroin users on buprenorphine versus methadone maintenance. Am J Drug Alcohol Abuse. 33:(5) 631-642.
15. RENO R. R., AIKEN L. S. (1993): Life activities and life quality of heroin addicts in and out of methadone treatment. Int J Addict. 28:(3) 211-232.
16. SOYKA M., ZINGG C., KOLLER G., KUEFNER H. (2008): Retention rate and substance use in methadone and buprenorphine maintenance therapy and predictors of outcome: results from a randomized study. Int J Neuropsychopharmacol 1-13.
17. TORRENS M., DOMINGO-SALVANY A., ALONSO J., CASTILLO C., SAN L. (1999): Methadone and quality of life. Lancet. 353:(9158) 1101.
18. VAN DEN BRINK W., HAASEN C. (2006): Evidenced-based treatment of opioid-dependent patients. Can J Psychiatry. 51:(10) 635-646.
19. VANAGAS G., PADAIGA Z., SUBATA E. (2004): Drug addiction maintenance treatment and quality of life measurements. Medicina (Kaunas). 40:(9) 833-841.
20. WALSH S. L., PRESTON K. L., BIGELOW G. E., STITZER M. L. (1995): Acute administration of buprenorphine in humans: partial agonist and blockade effects. J Pharmacol Exp Ther. 274:(1) 361-372.
21. WALSH S. L., PRESTON K. L., STITZER M. L., CONE E. J., BIGELOW G. E. (1994): Clinical pharmacology of buprenorphine: ceiling effects at high doses. Clin Pharmacol Ther. 55:(5) 569-580.
22. WOODS J. (2001): Methadone advocacy: the voice of the patient. Mt Sinai J Med. 68:(1) 75-78.